CaECT treatment induced systemic immune alterations across electroporation groups, including increased CD4<sup>+</sup> and CD8<sup>+</sup> memory T-cell populations in the spleen and reduced CD4<sup>+</sup> regulatory T cells and myeloid-derived suppressor cells in tumor-draining lymph nodes. The gene discussed is CD8A; the disease is neoplasm.